Sestrin2 Regulates Beneficial β3-Adrenergic Receptor-Mediated Effects Observed in Inguinal White Adipose Tissue and Soleus Muscle

Endocrinol Metab (Seoul). 2022 Jun;37(3):552-557. doi: 10.3803/EnM.2022.1421. Epub 2022 Jun 29.

Abstract

Sestrin2, a well-known adenosine monophosphate-activated protein kinase (AMPK) regulator, plays a protective role against metabolic stress. The β3-adrenergic receptor (β3AR) induces fat browning and inhibits muscle atrophy in an AMPK-dependent manner. However, no prior research has examined the relationship of sestrin2 with β3AR in body composition changes. In this study, CL 316,243 (CL), a β3AR agonist, was administered to wild-type and sestrin2-knockout (KO) mice for 2 weeks, and fat and muscle tissues were harvested. CL induced AMPK phosphorylation, expression of brown-fat markers, and mitochondrial biogenesis, which resulted in the reduction of lipid droplet size in inguinal white adipose tissue (iWAT). These effects were not observed in sestrin2-KO mice. In CL-treated soleus muscle, sestrin2-KO was related to decreased myogenic gene expression and increased levels of muscle atrophy-related molecules. Our results suggest that sestrin2 is associated with beneficial β3AR-mediated changes in body composition, especially in iWAT and in the soleus.

Keywords: Adipose tissue, brown; Adrenergic beta-3 receptor agonists; Muscle development; Muscular atrophy; Sestrin2 protein, mouse.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases* / metabolism
  • Adipose Tissue, White* / metabolism
  • Animals
  • Mice
  • Mice, Knockout
  • Muscle, Skeletal* / metabolism
  • Muscular Atrophy / metabolism
  • Receptors, Adrenergic, beta-3* / metabolism
  • Sestrins* / metabolism

Substances

  • Receptors, Adrenergic, beta-3
  • Sestrins
  • Sesn2 protein, mouse
  • AMP-Activated Protein Kinases